Rita Rubin

2.6k total citations · 2 hit papers
151 papers, 1.6k citations indexed

About

Rita Rubin is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Rita Rubin has authored 151 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 21 papers in Public Health, Environmental and Occupational Health and 19 papers in Economics and Econometrics. Recurrent topics in Rita Rubin's work include SARS-CoV-2 and COVID-19 Research (15 papers), Vaccine Coverage and Hesitancy (15 papers) and Opioid Use Disorder Treatment (14 papers). Rita Rubin is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (15 papers), Vaccine Coverage and Hesitancy (15 papers) and Opioid Use Disorder Treatment (14 papers). Rita Rubin collaborates with scholars based in United States. Rita Rubin's co-authors include Jennifer Abbasi, Rebecca Voelker and Melissa Suran and has published in prestigious journals such as JAMA and PubMed.

In The Last Decade

Rita Rubin

137 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

It Takes an Average of 17 Years for Evidence to Change Practice—the Burgeoning Field of Implementation Science Seeks to Speed Things Up

2023 65 citations Rita Rubin JAMA profile →
From “Immunity Debt” to “Immunity Theft”—How COVID-19 Might Be Tied to Recent Respiratory Disease Surges

2024 40 citations Rita Rubin JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rita Rubin United States	18	500	246	246	219	216	151	1.6k
Chuku Okorie Nigeria	10	803 1.6×	309 1.3×	222 0.9×	205 0.9×	231 1.1×	40	1.7k
Ingrid Torjesen Greenland	19	610 1.2×	183 0.7×	188 0.8×	154 0.7×	234 1.1×	362	1.9k
Brook Belay United States	14	564 1.1×	217 0.9×	281 1.1×	343 1.6×	205 0.9×	29	1.5k
Muhammad Sohaib Asghar Pakistan	17	455 0.9×	158 0.6×	122 0.5×	210 1.0×	174 0.8×	229	1.6k
Omid Dadras Iran	20	668 1.3×	220 0.9×	90 0.4×	179 0.8×	218 1.0×	118	1.4k
Jennifer Abbasi United States	23	541 1.1×	153 0.6×	248 1.0×	245 1.1×	176 0.8×	283	2.3k
Alexis L. Beatty United States	28	260 0.5×	249 1.0×	271 1.1×	232 1.1×	117 0.5×	73	3.0k
Huifen Li United States	21	427 0.9×	233 0.9×	92 0.4×	385 1.8×	297 1.4×	57	2.1k
Michael Liu United States	20	768 1.5×	114 0.5×	143 0.6×	217 1.0×	168 0.8×	77	1.9k
Lyudmyla Kompaniyets United States	18	1.0k 2.1×	542 2.2×	277 1.1×	199 0.9×	356 1.6×	46	2.1k

Countries citing papers authored by Rita Rubin

Since Specialization

Citations

This map shows the geographic impact of Rita Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Rubin more than expected).

Fields of papers citing papers by Rita Rubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Rubin. The network helps show where Rita Rubin may publish in the future.

Co-authorship network of co-authors of Rita Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Rubin. A scholar is included among the top collaborators of Rita Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Rubin. Rita Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Rubin, Rita. (2026). Millions Turn to AI Chatbots for Mental Health Support. JAMA. 335(5). 385–385.

2.

Rubin, Rita. (2025). State Laws Aim to Bring Internationally Trained Physicians to Underserved Areas, but Barriers Abound. JAMA. 334(19). 1693–1693.

3.

Rubin, Rita. (2024). Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky. JAMA. 332(5). 359–359.

4.

Rubin, Rita. (2024). What to Know About the Recent Rise in Parvovirus B19 Infections. JAMA. 332(15). 1226–1226. 2 indexed citations

5.

Rubin, Rita. (2024). When It Comes to SARS-CoV-2 Clearance, People Who Are Immunocompromised Are Not All Alike. JAMA. 331(9). 723–723.

6.

Rubin, Rita. (2023). Why Blood Type Seems to Be Linked With COVID-19 Risk. JAMA. 330(9). 795–795. 1 indexed citations

7.

Rubin, Rita. (2023). Critics Say New State “Conscience Laws” Give Physicians Carte Blanche to Refuse Patients. JAMA. 330(18). 1720–1720. 2 indexed citations

8.

Rubin, Rita. (2023). More Evidence That Hypertension Treatment Decisions Shouldn’t Depend Solely on In-Office Blood Pressure Readings. JAMA. 329(19). 1630–1630. 1 indexed citations

9.

Rubin, Rita. (2023). Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections—Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More. JAMA. 329(12). 963–963.

10.

Rubin, Rita. (2023). Large Cohort Study Finds Possible Association Between Postural Orthostatic Tachycardia Syndrome and COVID-19 Vaccination but Far Stronger Link With SARS-CoV-2 Infection. JAMA. 329(6). 454–454. 7 indexed citations

11.

Rubin, Rita. (2023). Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual COVID-19 Vaccines Proposed by the FDA. JAMA. 329(9). 697–697. 3 indexed citations

12.

Rubin, Rita. (2022). New Funding for Research Into Rare Diseases Treatments. JAMA. 328(19). 1898–1898.

13.

Rubin, Rita. (2022). Highlights From Digestive Disease Week—Pandemic-Related Decline in Colorectal Cancer Screening, Lack of Association Between Proton Pump Inhibitors and Dementia, and More. JAMA. 328(1). 8–8. 1 indexed citations

14.

Rubin, Rita, Jennifer Abbasi, & Melissa Suran. (2022). How Caring for Patients Could Change in a Post–Roe v Wade US. JAMA. 327(21). 2060–2060. 7 indexed citations

15.

Rubin, Rita. (2021). The Price of Success—How to Evaluate COVID-19 Vaccines When They’re Available Outside of Clinical Trials. JAMA. 325(10). 918–918. 3 indexed citations

16.

Rubin, Rita. (2020). Rural Veterans Less Likely to Get Medication for Opioid Use Disorder. JAMA. 323(4). 300–300. 6 indexed citations

17.

Rubin, Rita. (2020). Pandemic Highlights Behavioral Health Disparities. JAMA. 323(24). 2452–2452. 2 indexed citations

18.

Rubin, Rita. (2019). Why Are Mothers Still Passing Syphilis to Their Babies?. JAMA. 321(8). 729–729. 4 indexed citations

19.

Rubin, Rita. (2016). Doubling Cap on Patients Physicians Can Treat With Buprenorphine. JAMA. 315(18). 1938–1938. 1 indexed citations

20.

Rubin, Rita. (1995). The baby or the drug?. PubMed. 118(12). 59–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact